Specific skin manifestations in CD56 positive acute myeloid leukemia

Journal of Cutaneous Pathology

Volumn 26, Issue 1, 1999, Pages 1-5

  Kuwabara, Hiroko ^a   Nagai, Masami ^b   Yamaoka, Genji ^b   Ohnishi, Hiroaki ^b   Kawakami, Kimihiro ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; NERVE CELL ADHESION MOLECULE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; DERMIS; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SKIN MANIFESTATION; SUBCUTANEOUS TISSUE; TUMOR GROWTH;

ACUTE DISEASE; ADULT; ANTIGENS, CD56; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS;

EID: 0032919299     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1999.tb01782.x     Document Type: Article

References (26)

1. 1. Cunningham BA, Hemperly JJ, Murray BA, et al. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 1987: 236: 799.
2. 2. Hercend T, Griffin JD, Bensussan A, et al. Generation of monoclonal antibodies to a human natural killer clone: characterization of two natural killer-associated antigens, NKHIA and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 1985: 75: 932.
3. 3. Lanier LL, Testi R, Bindl J, Phillips JH. Identification of Leu19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989: 169: 2233.
4. 4. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995: 19: 284.
5. 5. Wong KF, Chan JKC, Ng CS, et al. CD56 (NKHI)-positive hematolymphoid malignancies. Hum Pathol 1992: 23: 798.
6. 6. Ansai S, Maeda K, Yamakawa M, et al. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. J Cutan Pathol 1997: 24: 468.
7. 7. Savoia P, Fierro MT, Novelli M, et al. CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997: 137: 966.
8. 8. Reuss-Borst MA, Steinke B, Waller HD, et al. Phenotypic and clinical heterogenety of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol 1992: 64: 78.
9. 9. Seymour JF, Pierce SA, Kantarjian HM, et al. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 1994: 8: 823.
10. 10. Mann KP, DeCastro CM, Liu J, et al. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol 1997: 107: 653.
11. 11. Bennet JM, Catovsky D, Daniel M-T, et al. Proposed revised criteria For the classification of acute myeloid leukemia. Ann Int Med 1985: 103: 620.
12. 12. Bennett JM, Catovsky D, Daniel M-T, et al. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol 1991: 78: 325.
13. 13. LeBoit PE, McCalmont TH. Cutaneous lymphomas and leukemias. In: Elder D, Elenitsas R, Jaworsky C, Johnson S Jr, eds. Lever's Histopathology of the Skin. Philadelphia: Lippincott-Raven, 1997: 840.
14. 14. Tsang WYW, Chan JKC, Ng CS, et al. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 1996: 20: 202.
15. 15. Sepp N, Radaszkiewicz T, Meijer CJLM, et al. Specific skin manifestations in acute leukemia with monocytic differentiation. Cancer 1993: 71: 124.
16. 16. Hameed A, Lowrey DM, Lichtenheld M, et al. Characterization of three serine esterases isolated from human IL-2 activated killer cells. J Immunol 1988: 141: 3142.
17. 17. Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t (8;21) (q22;q22) acute myeloblastic leukemia in children. Blood 1992: 80: 3182.
18. 18. Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997: 90: 2417.
19. 19. Scott AA, Head DR, Kopecky KJ, et al. HLA-DR-, CD33+, CD56+ , CD16-myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994: 84: 244.
20. 20. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994: 47: 278.
21. 21. Wasik MA, Sackstein R, Novick D, et al. Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2. Hum Pathol 1996: 27: 738.
22. 22. Mechtersheimer G, Staudter M, Moller P. Expression of the natural killer-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 1991: 51: 1300.
23. 23. Covault J, Sanes JR. Distribution of NCAM in synaptic and extrasynaptic portions of developing and adult skeletal muscles. J Cell Biol 1986: 102: 716.
24. 24. Iizuka Y, Aiso M, Oshimi K, et al. Myeloblastoma formation in acute myeloid leukemia. Leu Res 1992: 16: 665.
25. 25. Fairburn EA, Burgen ASV. The skin lesions of monocytic leukemia. Br J Cancer 1947: 1: 352.
26. 26. Buechner SA, Li CY, Su WPD. Leukemia cutis. A histopathologic study of 42 cases. Am J Dermatopathol 1985: 7: 109.